Redhill Biopharma
RDHL
#10337
Rank
A$4.19 M
Marketcap
$3.23
Share price
-12.95%
Change (1 day)
-84.00%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): A$15.65 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are A$35.74 Million. In 2022 the company made an earning of -A$0.12 Billion, an increase over its 2021 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) A$15.65 M-113.2%
2022 -A$0.12 Billion-26.68%
2021 -A$0.17 Billion28.32%
2020 -A$0.13 Billion80.06%
2019 -A$70.02 Million8.97%
2018 -A$64.26 Million-14.76%
2017 -A$75.39 Million55.07%
2016 -A$48.62 Million39.26%
2015 -A$34.91 Million96.9%
2014 -A$17.73 Million0.78%
2013 -A$17.6 Million16.93%
2012 -A$15.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$13.14 B 68,531.52%๐Ÿ‡ซ๐Ÿ‡ท France
A$35.10 B 183,161.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.27 B 37,875.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$72.37 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.47 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel